RF processing via chromatin accessibility/depletion restores RF stability in BRCA-deficient cells and confers chemoresistance in vitro. Poor prognosis in BRCA2 mutant ovarian cancer. The gene discussed is BRCA2; the disease is ovarian carcinoma.